Thomas Linden

Principal at TOL CMC Consulting

Speaker

Thomas is a biopharmaceutical leader with 25 years of leadership experience in the Pharma industry with tenures at Takeda, Novartis and Merck Co, Inc.. He has extensive expertise in early and late stage development of Biologics, Vaccines, Peptides, Gene therapy, Injection Devices, Diagnostic and Connected Software devices leading to successful original regulatory filings and product licensures including combination product registrations. Thomas holds a Ph.D. equivalent form the University of Duesseldorf and M.S. equivalent in Biochemistry from the University of Hannover, both in Germany. Thomas just started his own consulting business as Principal at TOL CMC Consulting.